116 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp01989 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | CCRF-CEM | Leukemia cancer | IC50 : 14.7 µg/ml |
| dbacp01990 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | HL-60 | Leukemia cancer | IC50 : 11.3 µg/ml |
| dbacp01991 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 8.2 µg/ml |
| dbacp01992 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | MOLT-4 | Leukemia cancer | IC50 : 17 µg/ml |
| dbacp01993 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | RPMI-8226 | Leukemia cancer | IC50 : 10.5 µg/ml |
| dbacp01994 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SR | Leukemia cancer | IC50 : 20.2 µg/ml |
| dbacp01995 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | MCF-7 | Breast cancer | IC50 : 15.1 µg/ml |
| dbacp01996 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | NCI/ADR-RES | Breast cancer | IC50 : 11.5 µg/ml |
| dbacp01997 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | MDA-MB-231 | Breast cancer | IC50 : 11.3 µg/ml |
| dbacp01998 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | HS578T | Breast cancer | IC50 : 11.7 µg/ml |
| dbacp01999 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | MDA-MB-435 | Breast cancer | IC50 : 11.3 µg/ml |
| dbacp02000 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | MDA-N | Breast cancer | IC50 : 10.6 µg/ml |
| dbacp02001 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | BT-549 | Breast cancer | IC50 : 12.9 µg/ml |
| dbacp02002 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | T-47D | Breast cancer | IC50 : 23.9 µg/ml |
| dbacp02003 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | A-549 | Lung cancer | IC50 : 11.7 µg/ml |
| dbacp02004 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | EKVX | Lung cancer | IC50 : 12.1 µg/ml |
| dbacp02005 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | HOP-62 | Lung cancer | IC50 : 12.6 µg/ml |
| dbacp02006 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | HOP-92 | Lung cancer | IC50 : 7.2 µg/ml |
| dbacp02007 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | NCI-H226 | Lung cancer | IC50 : 13.3 µg/ml |
| dbacp02008 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | NCI-H23 | Lung cancer | IC50 : 10.8 µg/ml |
| dbacp02009 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | NCI-H322M | Lung cancer | IC50 : 10.7 µg/ml |
| dbacp02010 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | NCI-H460 | Lung cancer | IC50 : 12.1 µg/ml |
| dbacp02011 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | NCI-H522 | Lung cancer | IC50 : 11.2 µg/ml |
| dbacp02012 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SF-268 | Brain tumor | IC50 : 12.4 µg/ml |
| dbacp02013 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SF-295 | Brain tumor | IC50 : 12.9 µg/ml |
| dbacp02014 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SF-539 | Brain tumor | IC50 : 9.5 µg/ml |
| dbacp02015 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SNB-19 | Brain tumor | IC50 : 13.8 µg/ml |
| dbacp02016 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SNB-75 | Brain tumor | IC50 : 15.5 µg/ml |
| dbacp02017 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | U-251 | Brain tumor | IC50 : 10.6 µg/ml |
| dbacp02018 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | LOXIMVI | Skin cancer | IC50 : 9.5 µg/ml |
| dbacp02019 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | MALME-3M | Skin cancer | IC50 : 10.9 µg/ml |
| dbacp02020 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | M14 | Skin cancer | IC50 : 15.1 µg/ml |
| dbacp02021 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SK-MEL-2 | Skin cancer | IC50 : 11.1 µg/ml |
| dbacp02022 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SK-MEL-5 | Skin cancer | IC50 : 8.9 µg/ml |
| dbacp02023 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | UACC-257 | Skin cancer | IC50 : 12.5 µg/ml |
| dbacp02024 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | UACC-62 | Skin cancer | IC50 : 10.6 µg/ml |
| dbacp02025 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | 786-0 | Renal cancer | IC50 : 12.2 µg/ml |
| dbacp02026 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | A-498 | Renal cancer | IC50 : 10 µg/ml |
| dbacp02027 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | ACHN | Renal cancer | IC50 : 12 µg/ml |
| dbacp02028 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | CAKI-1 | Renal cancer | IC50 : 14.1 µg/ml |
| dbacp02029 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | RFX393 | Renal cancer | IC50 : 11 µg/ml |
| dbacp02030 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SN-12C | Renal cancer | IC50 : 11.4 µg/ml |
| dbacp02031 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | TK-10 | Renal cancer | IC50 : 13.1 µg/ml |
| dbacp02032 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | UO-31 | Renal cancer | IC50 : 10.6 µg/ml |
| dbacp02033 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | IGROV1 | Ovarian cancer | IC50 : 9 µg/ml |
| dbacp02034 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | OVRCAR-3 | Ovarian cancer | IC50 : 15.2 µg/ml |
| dbacp02035 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | OVRCAR-4 | Ovarian cancer | IC50 : 17.6 µg/ml |
| dbacp02036 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | OVRCAR-5 | Ovarian cancer | IC50 : 13.8 µg/ml |
| dbacp02037 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | OVRCAR-8 | Ovarian cancer | IC50 : 13 µg/ml |
| dbacp02038 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SK-OV-3 | Ovarian cancer | IC50 : 12.6 µg/ml |
| dbacp02039 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | COLO-205 | Colon cancer | IC50 : 11.2 µg/ml |
| dbacp02040 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | HCT-116 | Colon cancer | IC50 : 14.6 µg/ml |
| dbacp02041 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | HCT-15 | Colon cancer | IC50 : 13.2 µg/ml |
| dbacp02042 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 17.6 µg/ml |
| dbacp02043 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | KM12 | Colon cancer | IC50 : 12 µg/ml |
| dbacp02044 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SW-620 | Colon cancer | IC50 : 12.7 µg/ml |
| dbacp02045 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | PC-3 | Prostate cancer | IC50 : 12 µg/ml |
| dbacp02046 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | DU-145 | Prostate cancer | IC50 : 15.3 µg/ml |
| dbacp02047 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | CCRF-CEM | Not specified | IC50 : 14.7 µg/ml |
| dbacp02048 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | HL-60 | Not specified | IC50 : 11.3 µg/ml |
| dbacp02049 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | K562 | Not specified | IC50 : 8.2 µg/ml |
| dbacp02050 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | MOLT4 | Not specified | IC50 : 17.0 µg/ml |
| dbacp02051 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | RPMI-8226 | Not specified | IC50 : 10.5 µg/ml |
| dbacp02052 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | SR | Not specified | IC50 : 20.2 µg/ml |
| dbacp02053 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | MCF-7 | Not specified | IC50 : 15.1 µg/ml |
| dbacp02054 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | NCI/ADR-RES | Not specified | IC50 : 11.5 µg/ml |
| dbacp02055 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | MDA-MB-231 | Not specified | IC50 : 11.3 µg/ml |
| dbacp02056 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | HS 578T | Not specified | IC50 : 11.7 µg/ml |
| dbacp02057 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | MDA-MB-435 | Not specified | IC50 : 11.3 µg/ml |
| dbacp02058 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | MDA-N | Not specified | IC50 : 10.6 µg/ml |
| dbacp02059 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | BT-549 | Not specified | IC50 : 12.9 µg/ml |
| dbacp02060 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | T-47D | Not specified | IC50 : 23.9 µg/ml |
| dbacp02061 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | A549 | Not specified | IC50 : 11.7 µg/ml |
| dbacp02062 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | EKVX | Not specified | IC50 : 12.1 µg/ml |
| dbacp02063 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | HOP-62 | Not specified | IC50 : 12.6 µg/ml |
| dbacp02064 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | HOP-92 | Not specified | IC50 : 7.2 µg/ml |
| dbacp02065 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | NCI-H226 | Not specified | IC50 : 13.3µg/ml |
| dbacp02066 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | NCI-H23 | Not specified | IC50 : 10.8 µg/ml |
| dbacp02067 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | NCI-H322M | Not specified | IC50 : 10.7 µg/ml |
| dbacp02068 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | NCI-H460 | Not specified | IC50 : 12.1 µg/ml |
| dbacp02069 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | NCI-H522 | Not specified | IC50 : 11.2 µg/ml |
| dbacp02070 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | SF-268 | Not specified | IC50 : 12.4 µg/ml |
| dbacp02071 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | SF-295 | Not specified | IC50 : 12.9 µg/ml |
| dbacp02072 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | SF-539 | Not specified | IC50 : 9.5 µg/ml |
| dbacp02073 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | SNB-19 | Not specified | IC50 : 13.8 µg/ml |
| dbacp02074 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | SNB-75 | Not specified | IC50 : 15.5 µg/ml |
| dbacp02075 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | U251 | Not specified | IC50 : 10.6 µg/ml |
| dbacp02076 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | LOX IMVI | Not specified | IC50 : 9.5 µg/ml |
| dbacp02077 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | MALME-3M | Not specified | IC50 : 10.9 µg/ml |
| dbacp02078 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | M14 | Not specified | IC50 : 15.1 µg/ml |
| dbacp02079 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | SK-MEL-2 | Not specified | IC50 : 11.1 µg/ml |
| dbacp02080 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | SK-MEL-5 | Not specified | IC50 : 8.9 µg/ml |
| dbacp02081 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | UACC-257 | Not specified | IC50 : 12.5µg/ml |
| dbacp02082 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | UACC-62 | Not specified | IC50 : 10.6 µg/ml |
| dbacp02083 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | 786-0 | Not specified | IC50 : 12.2 µg/ml |
| dbacp02084 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | A498 | Not specified | IC50 : 10 µg/ml |
| dbacp02085 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | ACHN | Not specified | IC50 : 12 µg/ml |
| dbacp02086 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | CAKI-1 | Not specified | IC50 : 14.1 µg/ml |
| dbacp02087 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | RFX 393 | Not specified | IC50 : 11 µg/ml |
| dbacp02088 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | SN12C | Not specified | IC50 : 11.1 µg/ml |
| dbacp02089 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | TK-10 | Not specified | IC50 : 13.1 µg/ml |
| dbacp02090 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | UO-31 | Not specified | IC50 : 10.6 µg/ml |
| dbacp02091 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | IGROV 1 | Not specified | IC50 : 9 µg/ml |
| dbacp02092 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | OVRCAR-3 | Not specified | IC50 : 15.2 µg/ml |
| dbacp02093 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | OVRCAR-4 | Not specified | IC50 : 17.6 µg/ml |
| dbacp02094 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | OVRCAR-5 | Not specified | IC50 : 13.8 µg/ml |
| dbacp02095 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | OVRCAR-8 | Not specified | IC50 : 13 µg/ml |
| dbacp02096 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | SKOV3 | Not specified | IC50 : 12.6 µg/ml |
| dbacp02097 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | COLO-205 | Not specified | IC50 : 11.2 µg/ml |
| dbacp02098 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | HCT116 | Not specified | IC50 : 14.6 µg/ml |
| dbacp02099 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | HT-29 | Not specified | IC50 : 13.2 µg/ml |
| dbacp02100 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | HCT-15 | Not specified | IC50 : 12 µg/ml |
| dbacp02101 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | KM12 | Not specified | IC50 : 12 µg/ml |
| dbacp02102 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | SW-620 | Not specified | IC50 : 12.7 µg/ml |
| dbacp02103 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | HCT-15 | Not specified | IC50 : 17.6 µg/ml |
| dbacp02104 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | DU-145 | Not specified | IC50 : 15.3 µg/ml |